REFERENCES
- Herd CM, Page CP. Pulmonary immune cells in health and disease: platelets. Eur Respir J. 1994;7:1145–1160. [INFOTRIEVE], [CSA]
- Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1–8. [INFOTRIEVE], [CSA]
- Carmeliet P, Collen D. Molecules in focus—tissue factor. Int J Biochem Cell Biol. 1998;30:661–667. [INFOTRIEVE], [CSA], [CROSSREF]
- McVey JH. Tissue factor pathway. Baillieres Best Pract Res Clin Haematol. 1999;12:361–372. [INFOTRIEVE], [CSA]
- Butenas S, Mann KG. Blood coagulation. Biochemistry. 2002;67:3–12. [INFOTRIEVE], [CSA]
- Camera M, Giesen PL, Fallon J, , et al. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler. Thromb Vasc Biol. 1999;19:531–537. [CSA]
- Lowe GD, Rumley A, Mackie IJ. Plasma fibrinogen. Ann Clin Biochem. 2004;41:430–440. [INFOTRIEVE], [CSA], [CROSSREF]
- Collen, D. Metabolism and distribution of fibrinogen. Br J Haematol. 1972;22:681–700. [INFOTRIEVE], [CSA]
- Henry I, Uzan G, Weil D, , et al. The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet. 1984;36:760–768. [INFOTRIEVE], [CSA]
- Matsuda M, Sugo T. Hereditary disorders of fibrinogen. Ann N Y Acad Sci. 2001;936:65–88. [INFOTRIEVE], [CSA]
- Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol. 2001;114:249–257. [INFOTRIEVE], [CSA], [CROSSREF]
- Henschen A. Covalent structure of fibrinogen. Ann N Y Acad Sci. 1983;408:28–43. [INFOTRIEVE], [CSA]
- Everse SJ, Spraggon G, Doolittle RF. A three-dimensional consideration of variant human fibrinogens. Thromb Haemost. 1998;80:1–9. [INFOTRIEVE], [CSA]
- Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of fibrin clot rheology. Biophys J. 1999;77:2813–2826. [INFOTRIEVE], [CSA]
- Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci. 2001;936:312–327. [INFOTRIEVE], [CSA]
- Meh DA, Mosesson MW, DiOrio JP, , et al. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagul Fibrinolysis. 2001;12:627–637. [INFOTRIEVE], [CSA], [CROSSREF]
- McDonagh J, Carrel N, Lee MH. Dysfibrinogenemia and other disorders of fibrinogen structure and function. In: Colman RW, Hirsh J, Marder V, , et al., eds. Haemostasis and Thrombosis: Basic Principles and Clinical Practice, ed 3. Philadelphia: JB Lippincott; 1994.
- Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia: report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemostat. 1995;73:151. [CSA]
- Franz RC. Fibrinogen Pretoria—a clinical and biochemical study of a Pretoria family with fibrinogen dysfunction resulting from a gamma chain defect. SAMJ. 2002;92:968–970. [INFOTRIEVE], [CSA]
- Ebert R. Index of Variant Human Fibrinogens. Boca Raton, FL: CRC Press; 1994.
- Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 1997;389:455–462. [INFOTRIEVE], [CSA], [CROSSREF]